Phorbol ester / хорт хавдар

Compositions and methods of use of phorbol esters in the treatment of neoplasms

Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой

Нэвтрэх / Бүртгүүлэх

ADDITIONAL DISCLOSURES Additional disclosures relating to the instant application may be found in "Compositions And Methods Of Use Of Phorbol Esters" U.S. patent application Ser. No. 12/023,753, filed Jan. 31, 2008, to Richard L. Chang, et al, which claims priority benefit of U.S. Provisional Patent

Compositions and methods of use of phorbol esters in the treatment of neoplasms

Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой

Нэвтрэх / Бүртгүүлэх

ADDITIONAL DISCLOSURES Additional disclosures relating to the instant application may be found in "Compositions And Methods Of Use Of Phorbol Esters" U.S. patent application Ser. No. 12/023,753, filed Jan. 31, 2008, to Richard L. Chang, et al, which claims priority benefit of U.S. Provisional Patent

Compositions and methods of use of phorbol esters in the treatment of neoplasms

Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой

Нэвтрэх / Бүртгүүлэх

ADDITIONAL DISCLOSURES Additional disclosures relating to the instant application may be found in "Compositions And Methods Of Use Of Phorbol Esters" U.S. patent application Ser. No. 12/023,753, filed Jan. 31, 2008, to Richard L. Chang, et al, which claims priority benefit of U.S. Provisional Patent

Phorbol esters as anti-neoplastic and white blood cell elevating agents

Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой

Нэвтрэх / Бүртгүүлэх

BRIEF DESCRIPTION OF THE INVENTION The invention relates to treating neoplastic disease such as leukemia and increasing the white blood cell counts in patients suffering from neoplastic diseases or undergoing chemotherapy by a method which comprises administering parenterally to patients an

Phorbol ester pharmaceutical compositions and their use for treating inflammation

Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой

Нэвтрэх / Бүртгүүлэх

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method of inhibiting protein kinase C function and to compounds and compositions suitable for use in such a method. 2. Background Information In mouse skin, phorbol esters exert tumor promoting, inflammatory,

Tumor treatment method

Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой

Нэвтрэх / Бүртгүүлэх

FIELD OF THE INVENTION The present invention relates to a method of treating a solid tumor, and in particular, to a method involving hypoxic stress as one component and protein kinase C activation as another component. REFERENCES Cook, P. F., et al., Biochem. 21: 5794-5799 (1982). Culver, K., et

Compositions and methods of use of phorbol esters

Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой

Нэвтрэх / Бүртгүүлэх

TECHNICAL FIELD The present invention relates generally to the medicinal use of phorbol esters. BACKGROUND Plants have historically served many medicinal purposes. The World Health Organization (WHO) estimates that 4 billion people, 80% of the world population, presently use herbal medicine for some

Compositions and methods of use of phorbol esters

Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой

Нэвтрэх / Бүртгүүлэх

TECHNICAL FIELD The present invention relates generally to the medicinal use of phorbol esters. BACKGROUND Plants have historically served many medicinal purposes. The World Health Organization (WHO) estimates that 4 billion people, 80% of the world population, presently use herbal medicine for some

Compositions and methods of use of phorbol esters

Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой

Нэвтрэх / Бүртгүүлэх

TECHNICAL FIELD The present invention relates generally to the medicinal use of phorbol esters. BACKGROUND Plants have historically served many medicinal purposes. The World Health Organization (WHO) estimates that 4 billion people, 80% of the world population, presently use herbal medicine for some

Method of inhibiting hyperplasia to a mammal in need thereof

Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой

Нэвтрэх / Бүртгүүлэх

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method of inhibiting protein kinase C function and to compounds and compositions suitable for use in such a method. 2. Background Information In mouse skin, phorbol esters exert tumor promoting, inflammatory,

Matrix metalloproteinase inhibitor peptides

Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой

Нэвтрэх / Бүртгүүлэх

BACKGROUND OF THE INVENTION 1. Field of the Invention This invention relates to isolated proteins or peptides useful for inhibition of matrix metalloproteinases. Specifically, this invention relates to a novel protein, isolated from conditioned media of cultured human tumor cells, which binds with

Inhibition of nuclear transcription factor NF-.kappa.B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin

Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой

Нэвтрэх / Бүртгүүлэх

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates generally to inhibitors of nuclear transcription factor NF-.kappa.B, and the use of these inhibitors in the treatment of pathological conditions in humans. Specifically, the present invention relates to the

Lymphotoxin-.beta., lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof

Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой

Нэвтрэх / Бүртгүүлэх

TECHNICAL FIELD OF THE INVENTION This invention relates to lymphotoxin-.beta., a lymphocyte membrane-type polypeptide. Lymphotoxin-.beta., also referred to as p33, has been identified on the surface of T lymphocytes, T cell lines, B cell lines and lymphokine-activated killer cells. This invention

Lymphotoxin-.beta., Lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof

Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой

Нэвтрэх / Бүртгүүлэх

TECHNICAL FIELD OF THE INVENTION This invention relates to lymphotoxin-.beta., a lymphocyte membrane-type polypeptide. Lymphotoxin-.beta., also referred to as p33, has been identified on the surface of T lymphocytes, T cell lines, B cell lines and lymphokine-activated killer cells. This invention

Lymphotoxin-beta and lymphotoxin-beta complexes

Зөвхөн бүртгэлтэй хэрэглэгчид л нийтлэл орчуулах боломжтой

Нэвтрэх / Бүртгүүлэх

TECHNICAL FIELD OF THE INVENTION This invention relates to lymphotoxin-.beta., a lymphocyte membrane-type polypeptide. Lymphotoxin-.beta., also referred to as p33, has been identified on the surface of T lymphocytes, T cell lines, B cell lines and lymphokine-activated killer cells. This invention

phorbol ester/хорт хавдар

Compositions and methods of use of phorbol esters in the treatment of neoplasms

Compositions and methods of use of phorbol esters in the treatment of neoplasms

Compositions and methods of use of phorbol esters in the treatment of neoplasms

Phorbol esters as anti-neoplastic and white blood cell elevating agents

Phorbol ester pharmaceutical compositions and their use for treating inflammation

Tumor treatment method

Compositions and methods of use of phorbol esters

Compositions and methods of use of phorbol esters

Compositions and methods of use of phorbol esters

Method of inhibiting hyperplasia to a mammal in need thereof

Matrix metalloproteinase inhibitor peptides

Inhibition of nuclear transcription factor NF-.kappa.B by caffeic acid phenethyl ester (CAPE), derivatives of CAPE, capsaicin (8-methyl-N-vanillyl-6-nonenamide) and resiniferatoxin

Lymphotoxin-.beta., lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof

Lymphotoxin-.beta., Lymphotoxin-.beta. complexes, pharmaceutical preparations and therapeutic uses thereof

Lymphotoxin-beta and lymphotoxin-beta complexes

Шинжлэх ухаанаар баталгаажсан эмийн өвс ургамлын бүрэн мэдээллийн сан